๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Wahroonga
Clinical trial register · Australia

Clinical Trials in Wahroonga, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 3331 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:46 UTC
3331
Studies in scope
all four open statuses
1807
Recruiting now
open to new participants
758
Lead sponsors
across recruiting studies
Top sites
Melbourne 1087 Adelaide 564 Sydney 508 Westmead 416 Clayton 409
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Janssen Research & Development, LLC3 Celcuity Inc2 Hefei Xinzhu Biological Technology Co., Ltd.1 Merck Sharp & Dohme LLC1 Australian and New Zealand Urogenital and Prostate Cancer Trials Group1
Site location
Melbourne1087 Adelaide564 Sydney508 Westmead416 Clayton409
All 397 locations
Target enrolment
to

Trials with a site in Wahroonga

38 of 3331 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
A Phase 1a/1b, First-Time-in-Human Study of CT-202, a Nectin-4 Directed Bispecific Antibody, in Participants With Recurring Triple Negative Breast, Colorectal, Urothelial Cancers
NCT07545122Triple Negative Breast Cancer (TNBC), Colorectal Cancer, Urothelial Cancer
Context Therapeutics Inc.
Phase 1
162
Wahroonga, Gold Coast, Newcastle, Perth
2026-09
Recruiting
N-3C01 Monotherapy and Combination With PD-(L)1 Inhibitors in Advanced Solid Tumors
NCT07639450Advanced Malignant Solid Tumors
DrugPembrolizumab
Hefei Xinzhu Biological Technology Co., Ltd.
Phase 1/2
114
Saint Leonards, Wahroonga, Waratah
2026-06-15
Not yet open
ITX24-01 in Adult Male and Female Patients With Select Types of Severe Chronic Neck- and Lower Back Pain
NCT07520240Facet Joint Pain
Interventional AnalgesiX Inc.
Phase 1
32
Wahroonga
2026-06-01
Recruiting
Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis
NCT07303777Atherosclerosis Cardiovascular Disease, ASCVD, ASCVD Management
DrugsABP-745 A·ABP-745 B
Atom Therapeutics Co., Ltd
Phase 2
200
Newcastle, Morayfield, Brisbane, Wahroonga
2026-04-23
Recruiting
Study to Assess the Safety and Pharmacokinetics of AVD275 Injection in Patients With Osteoarthritis of the Knee
NCT07338266Osteoarthritis of the Knee
Avidence Therapeutics
Phase 1
15
Wahroonga
2026-01-22
Recruiting
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
NCT07225946Prostatic Neoplasms, Castration-Resistant
DrugsPasritamig·Prednisone/Prednisolone·Docetaxel
Janssen Research & Development, LLC
Phase 3
800
Heidelberg, Kurralta Park, Melbourne, Wahroonga, Woolloongabba
2025-12-19
Recruiting
Study to Evaluate Safety of C-1101 Versus Sterile Saline in Adults With Chronic Painful Lumbosacral Radiculopathy
NCT07264270Lumbosacral Radicular Pain, Sciatic Radiculopathy, Sciatic Leg Pain, Sciatica
Consano Bio
Phase 1
24
Broadmeadow, Wahroonga, Melbourne
2025-12-03
Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naรฏve.
NCT07028853Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate
DrugsMevrometostat·Xtandi·Enzalutamide
Pfizer
Phase 3
1,000
Orange, Wahroonga, South Brisbane, Kurralta Park, Nedlands
2025-09-28
Recruiting
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
NCT06982521PIK3CA Mutation, HER2- Negative Breast Cancer, Hormone Receptor Positive Tumor, Breast Cancer
DrugsCapivasertib·Fulvestrant
Relay Therapeutics, Inc.
Phase 3
540
Darlinghurst, Gateshead, North Sydney, Wahroonga, Clayton, Geelong, Melbourne, Saint Albans
2025-08-26
Recruiting
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
NCT06757634Breast Cancer
DrugsGedatolisib·Ribociclib·Palbociclib·Letrozole
Celcuity Inc
Phase 3
1,180
Adelaide, Nedlands, Southport, Wahroonga, Westmead, Woodville
2025-07-24
Active, closed
64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer
NCT06970847Prostate Cancer, Prostate Cancer Patients With Detectable PSA Following Prostatectomy, Prostate Cancer Recurrent, Prostate Cancer Patients Who Have Brachytherapy Seed Implant
Drug64Cu-SAR-bisPSMA
Clarity Pharmaceuticals Ltd
Phase 3
220
Darlinghurst, Wahroonga, Westmead, Herston
2025-05-16
Recruiting
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
NCT06819891Moderately to Severely Active Crohns Disease
DrugAfimkibart
Hoffmann-La Roche
Phase 3
425
Macquarie Park, Wahroonga, Mackay, Footscray, Parkville
2025-05-12
Recruiting
Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003
NCT06714006Autosomal Dominant Polycystic Kidney Disease (ADPKD)
PYC Therapeutics
Phase 1
166
Southport, Concord, Liverpool, Randwick, Wahroonga, Westmead, South Brisbane, Fitzroy
2025-04-07
Not yet open
Accelerated Partial Breast Irradiation Using External Beam Volumetric Modulated Arc Therapy (VMAT): a Randomised Non-inferiority Trial of 30 Gy Versus 26 Gy in Five Fractions Investigating Patient-reported Outcomes
NCT06909032Breast Cancer
Integrated Community Oncology Network
Not applicable
168
Wahroonga, Windsor Gardens
2025-04
Active, closed
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
NCT06764485Metastatic Castration-resistant Prostate Cancer
DrugsAbiraterone·Enzalutamide·Docetaxel
Celgene
Phase 3
960
Campbelltown, Darlinghurst, Macquarie University, Port Macquarie, Wahroonga, Greenslopes, Southport, Adelaide
2025-03-13
Active, closed
ASCEND: A Clinical Trial to Evaluate the Safety and Effectiveness of VIA Disc NP, a Supplement for Degenerated Intervertebral Discs
NCT06615505Degenerative Disc Disease, Disc Degeneration, Lumbar Discogenic Pain
VIVEX Biologics, Inc.
Phase 2
121
Broadmeadow, Hurstville, Wahroonga, Wayville, Clayton
2024-10-04
Recruiting
Working Out M0 Bipolar Androgen Therapy
NCT06594926Prostate Cancer
DrugTestosterone Enanthate
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Phase 2
69
Garran, Albury, Darlinghurst, St Leonards, Wahroonga, Chermside, South Brisbane, Adelaide
2024-08-14
Active, closed
RT-310 Dose Escalation BPH Study
NCT06136819BPH (Benign Prostatic Hyperplasia), Lower Urinary Tract Symptoms
Resurge Therapeutics Inc.
Phase 1
20
Wahroonga, Bendigo, Maribyrnong
2024-04-19
Active, closed
A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies
NCT05794906Biochemically Recurrent Prostate Cancer
DrugDarolutamide
Bayer
Phase 3
985
Camperdown, Epping, Liverpool, Wahroonga, Adelaide, Box Hill, East Melbourne, Geelong
2023-04-03
Active, closed
Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)
NCT05501886Breast Cancer
DrugsGedatolisib·Alpelisib·Palbociclib·Fulvestrant
Celcuity Inc
Phase 3
701
Adelaide, Fitzroy, Frankston, Nedlands, South Brisbane, Southport, Wahroonga, Woodville
2022-12-08
Recruiting
Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC
NCT05393791Prostatic Neoplasms, Castration-Resistant
DrugsZytiga·Xtandi·Abiraterone acetate·Enzalutamide
Leiden University Medical Center
Phase 2
168
Albury, Camperdown, Kogarah, Newcastle, St Leonards, Wahroonga, Birtinya, South Brisbane
2022-11-10
Recruiting
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
NCT05413421Metastatic Prostate Cancer
DrugsDarolutamide (Nubeqa)·Rinzimetostat·Apalutamide (Erleada)
ORIC Pharmaceuticals
Phase 1
275
Wahroonga, Bendigo, Frankston
2022-06-01
Active, closed
Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)
NCT05348577Prostate Cancer
DrugsCapivasertib·Docetaxel
AstraZeneca
Phase 3
1,035
Birtinya, Greenslopes, Kogarah, North Adelaide, Orange, Redcliffe, Wahroonga
2022-03-25
Active, closed
A First in Human Feasibility Study to Evaluate the Safety and Effectiveness of the BIOTRONIK Prospera SCS System with HomeStream Remote Management
NCT04683718Chronic Low-back Pain, Chronic Leg Pain
Biotronik, Inc.
Not applicable
60
Broadmeadow, Hurstville, Wahroonga, Noosa, Clayton
2021-09-20
Active, closed
REZลชM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active Men
NCT04838769Benign Prostatic Hyperplasia (BPH)
Boston Scientific Corporation
Not applicable
155
Melbourne, Wahroonga
2021-09-15
Active, closed
Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma
NCT04674683Unresectable or Metastatic Melanoma, Progressive Brain Metastasis
DrugsChidamide·Nivolumab
HUYABIO International, LLC.
Phase 3
450
Wahroonga, Buderim, South Brisbane, Ballarat, Shepparton, Brisbane, Liverpool, Nedlands
2021-08-12
Recruiting
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naรฏve
NCT04752722Superficial Bladder Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ, Non-muscle Invasive Bladder Cancer
DrugPhase 2
enGene, Inc.
Phase 1/2
350
Wahroonga, Southport, Windsor Gardens
2021-04-22
Active, closed
A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy
NCT03767244Prostatic Neoplasms
DrugApalutamide
Janssen Research & Development, LLC
Phase 3
2,517
Box Hill, Darlinghurst, Heidelberg, Malvern, Parkville, St Leonards, Wahroonga, Westmead
2019-06-11
Active, closed
Phase III Study in First-line Treatment of Patients With Metastatic Colorectal Cancer Who Are Not Candidate for Intensive Therapy.
NCT03869892Metastatic Colorectal Cancer
DrugsTrifluridine/Tipiracil·Capecitabine
Institut de Recherches Internationales Servier
Phase 3
856
Blacktown, Frankston, Gateshead, Kogarah, Wahroonga, Wollongong
2019-03-21
Active, closed
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)
NCT03711032High-risk Non-muscle Invasive Bladder Cancer
DrugsKeytruda·Pembrolizumab
Merck Sharp & Dohme LLC
Phase 3
1,397
St Leonards, Wahroonga, Richmond
2018-12-24
Active, closed
A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer
NCT03701334Early Breast Cancer
DrugRibociclib
Novartis Pharmaceuticals
Phase 3
5,101
Campbelltown, Coffs Harbour, Darlinghurst, Kingswood, Kogarah, North Ryde, St Leonards, Wahroonga
2018-12-07
Active, closed
A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.
NCT03539744Multiple Myeloma
DrugsPomalidomide·Venetoclax·Dexamethasone
AbbVie
Phase 3
265
Liverpool, Wahroonga, Wollongong, Hyde Park, South Brisbane, Woodville South, Nedlands
2018-10-22
Active, closed
Post Market Clinical Follow-up (PMCF) Study of the A.L.P.S. Proximal Humerus Plating System
NCT03626038Osteoarthritis, Rheumatoid Arthritis, Post-Traumatic Arthritis, Psoriatic Arthritis
Zimmer Biomet
Not applicable
135
Wahroonga
2018-06-19
Active, closed
Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients
NCT02922036Heart Failure
EBR Systems, Inc.
Not applicable
300
Garran, New Lambton Heights, Randwick, Wahroonga, Chermside, Adelaide, Clayton, Parkville
2018-01-17
Active, closed
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
NCT02960022Prostate Cancer
DrugsLeuprolide Acetate·Abiraterone acetate·Enzalutamide·Prednisone
Astellas Pharma Global Development, Inc.
Phase 2
900
Albury, Tweed Heads, Wahroonga, Ashford, Ballarat, East Bentleigh, Malvern, Parkville
2016-12-22
Active, closed
A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer
NCT02246621Breast Cancer
DrugsAnastrozole·Abemaciclib·Letrozole
Eli Lilly and Company
Phase 3
493
Camperdown, Sydney, Wahroonga, South Brisbane, Woolloongabba, Woodville, Geelong, Murdoch
2014-11-06
Recruiting
Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
NCT02582697Germ Cell Tumor
DrugsFilgrastim·Pegfilgrastim·Bleomycin·Etoposide
University of Sydney
Phase 3
500
Newcastle, St Leonards, Sydney, Wahroonga, Brisbane, South Brisbane, Woolloongabba, Adelaide
2014-02
Recruiting
A Long-term Extension Study of PCI-32765 (Ibrutinib)
NCT01804686Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
DrugIbrutinib
Janssen Research & Development, LLC
Phase 3
700
Adelaide, Coburg, Concord, Heidelberg, Melbourne, Perth, Prahran, Wahroonga
2013-09-09
Rows per page Showing 1–38 of 38
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-australia/city/wahroonga

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,331 studies in total at the last sync on 26 Sep 2026, 19:46 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 38 of those studies with a site in Wahroonga.

How many clinical trials are recruiting in Wahroonga?

17 of the 38 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:46 UTC sync. A further 2 have not yet opened recruitment, 19 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Wahroonga), 38 studies
PhaseStudiesRecruitingShare
Phase 319750%
Phase 17518.4%
Not applicable5013.2%
Phase 25313.2%
Phase 1/2225.3%

Most active sponsors

Lead sponsors with the most studies (Wahroonga)
Lead sponsorStudiesRecruiting
Janssen Research & Development, LLC32
Celcuity Inc21
AbbVie10
Astellas Pharma Global Development, Inc.10
AstraZeneca10
Atom Therapeutics Co., Ltd11
Australian and New Zealand Urogenital and Prostate Cancer Trials Group11
Avidence Therapeutics11
Bayer10
Biotronik, Inc.10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.